Flint

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin